Related Experiment Video
Updated: Jan 17, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Akkermansia muciniphila ameliorates Salmonella-induced colitis and intestinal fibrosis
Abdulhadi Suwandi1, Soeren Ocvirk2, Alibek Galeev3
1Institute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany; Institute of Cell Biochemistry, Hannover Medical School, Hannover, Germany; German Center for Infection Research (DZIF), partner site Hannover-Braunschweig, Hannover, Germany.
Abstract:
Salmonella enterica serovar Typhimurium is a food-borne pathogen and a major cause of gastroenteritis in humans. The intestinal microbiota provides colonization resistance to enteric pathogens such as S. Typhimurium. Akkermansia muciniphila is an anaerobic bacterium commonly found in the intestinal tract of humans and other mammals and specializes in the degradation of mucin. To study the role of A. muciniphila in affecting the outcome of S. Typhimurium colonization and pathology, we used gnotobiotic mice colonized with a defined simplified human (SIHUMI) or mouse (OMM11) intestinal microbiota and infected them with the attenuated S. Typhimurium ΔaroA strain. By comparing SIHUMI and OMM11 mice to mice additionally colonized with A. muciniphila, we demonstrate that the presence of A. muciniphila leads to a decrease in intestinal Salmonella colonization. In addition, Salmonella-induced colitis is significantly reduced in the presence of A. muciniphila including improved histopathological changes as well as decreased levels of inflammatory cytokines. Furthermore, we demonstrate that viable A. muciniphila inhibit adhesion of Salmonella to the intestinal epithelium in vivo as well as to differentiated, polarized HT29-MTX-E12 epithelial cells. These data indicate that A. muciniphila plays an important role in mediating protection from S. Typhimurium colitis by inhibiting adhesion of Salmonella to the intestinal epithelium.
Insights
Akkermansia muciniphila reduces Salmonella Typhimurium colonization and colitis severity in mice. This beneficial bacterium inhibits Salmonella adhesion to the intestinal lining, offering protection against infection.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Salmonella enterica serovar Typhimurium is a significant foodborne pathogen causing human gastroenteritis.
- The gut microbiota confers resistance against enteric pathogen colonization.
- Akkermansia muciniphila is an intestinal bacterium known for mucin degradation.
Purpose of the Study:
- To investigate the role of Akkermansia muciniphila in modulating Salmonella Typhimurium colonization and associated pathology.
- To assess the impact of A. muciniphila on Salmonella-induced colitis in a mouse model.
Main Methods:
- Utilized gnotobiotic mice colonized with simplified human (SIHUMI) or mouse (OMM11) microbiota.
- Infected mice with an attenuated Salmonella Typhimurium strain (ΔaroA).
- Compared colonization and pathology in mice with and without A. muciniphila co-colonization.
Main Results:
- A. muciniphila presence significantly decreased intestinal Salmonella colonization.
- Salmonella-induced colitis was reduced, with improved histopathology and lower inflammatory cytokine levels.
- Viable A. muciniphila inhibited Salmonella adhesion to intestinal epithelium in vivo and in vitro.
Conclusions:
- Akkermansia muciniphila plays a protective role against Salmonella Typhimurium infection.
- A. muciniphila mitigates Salmonella-induced colitis by inhibiting pathogen adhesion to the gut lining.
More Related Videos
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
08:34Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022